Longport, Inc. Stock Other OTC

Longport, Inc. develops, manufactures, markets and sells ultrasound imaging systems. The Company focuses on high resolution medical ultrasound. The Company focuses on providing imaging systems that help in the prevention, assessment and treatment of medical conditions. The Company offers a high-resolution ultrasound (HRUS) imaging system, EPISCAN I-200, which utilizes ultrasound to image the skin and underlying soft tissue. EPISCAN I-200 can be connected to a range of interchangeable imaging probes that enable the imaging of the skin and underlying soft tissue at frequencies between 20 megahertz (MHz) and 50 MHz. EPISCAN is utilized in a range of clinical applications, as well as in research and development. EPISCAN enables the examination of tissue at a microscopic level. Its technology is used in a range of applications, such as wound assessment and prevention, dermatology, aesthetics, and research, including validation of processes and products that impact the skin.